Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-000871
Filing Date
2021-02-02
Accepted
2021-02-02 09:37:39
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2681932
2 filename2.htm EX-10.7 669530
3 GRAPHIC g19910g0201212702325.jpg GRAPHIC 5044
4 GRAPHIC g19910g04d64.jpg GRAPHIC 38009
5 GRAPHIC g19910g11m86.jpg GRAPHIC 56468
6 GRAPHIC g19910g17t35.jpg GRAPHIC 81004
7 GRAPHIC g19910g18q03.jpg GRAPHIC 69198
8 GRAPHIC g19910g26q63.jpg GRAPHIC 99683
9 GRAPHIC g19910g32s63.jpg GRAPHIC 631373
10 GRAPHIC g19910g32w78.jpg GRAPHIC 131527
11 GRAPHIC g19910g39u54.jpg GRAPHIC 620416
12 GRAPHIC g19910g44w12.jpg GRAPHIC 79629
13 GRAPHIC g19910g50k03.jpg GRAPHIC 37351
14 GRAPHIC g19910g61e40.jpg GRAPHIC 46663
15 GRAPHIC g19910g71l93.jpg GRAPHIC 94926
16 GRAPHIC g19910g96w28.jpg GRAPHIC 605101
17 GRAPHIC g19910g98e91.jpg GRAPHIC 39422
18 GRAPHIC g19910g99t25.jpg GRAPHIC 72972
19 GRAPHIC g19910st4.jpg GRAPHIC 3121
  Complete submission text file 0000950123-21-000871.txt   7003069
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX 44 (0) 1438 906855
Achilles Therapeutics Ltd (Filer) CIK: 0001830749 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03834 | Film No.: 21579294
SIC: 2836 Biological Products, (No Diagnostic Substances)